68 related articles for article (PubMed ID: 18374824)
1. Pharmacotherapy of first-episode schizophrenia.
Rosenheck RA
Lancet; 2008 Mar; 371(9618):1048-9. PubMed ID: 18374824
[No Abstract] [Full Text] [Related]
2. Sertindole versus haloperidol for schizophrenia.
Mattes JA
Am J Psychiatry; 1998 Sep; 155(9):1303; author reply 1303-4. PubMed ID: 9734567
[No Abstract] [Full Text] [Related]
3. Sertindole versus haloperidol for schizophrenia.
Balon R
Am J Psychiatry; 1998 Sep; 155(9):1303-4. PubMed ID: 9734566
[No Abstract] [Full Text] [Related]
4. Interpreting and applying the EUFEST results using number needed to treat: antipsychotic effectiveness in first-episode schizophrenia.
Citrome L
Int J Clin Pract; 2008 May; 62(5):837-40. PubMed ID: 18412940
[No Abstract] [Full Text] [Related]
5. An importance of dose in antipsychotic combination therapy for schizophrenia.
Suzuki T
J Clin Psychopharmacol; 2011 Jun; 31(3):399; author reply 399-400. PubMed ID: 21532376
[No Abstract] [Full Text] [Related]
6. Efficacy and safety of tiospirone vs. haloperidol and thioridazine in a double-blind, placebo-controlled trial.
Borison RL; Sinha D; Haverstock S; McLarnon MC; Diamond BI
Psychopharmacol Bull; 1989; 25(2):190-3. PubMed ID: 2574893
[No Abstract] [Full Text] [Related]
7. The AMDP system in international clinical trials: a double-blind comparison of fluperlapine and haloperidol.
Woggon B; Linden M; Beckmann H; Krebs E; Küfferle B; Müller-Oerlinghausen B; Pflug B; Schied HW
Psychopharmacol Bull; 1986; 22(1):47-51. PubMed ID: 2873619
[No Abstract] [Full Text] [Related]
8. [Antipsychotic drug combinations in the treatment of schizophrenia. A review of the literature].
Gazdag G; Tolna J; Bitter I
Neuropsychopharmacol Hung; 2012 Sep; 14(3):189-95. PubMed ID: 22987732
[TBL] [Abstract][Full Text] [Related]
9. Haloperidol versus chlorpromazine for treatment of schizophrenia.
Leucht C; Kitzmantel M; Chua L; Kane J; Leucht S
Schizophr Bull; 2008 Sep; 34(5):813-5. PubMed ID: 18658127
[No Abstract] [Full Text] [Related]
10. Sulpiride--an antipsychotic agent: comparative trial vs. haloperidol.
Cassano GB; Castrogiovanni P; Conti L; Bonollo L
Psychopharmacol Bull; 1977 Jul; 13(3):41-3. PubMed ID: 18759
[No Abstract] [Full Text] [Related]
11. Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind trial.
Fleischhacker WW; Barnas C; Stuppäck CH; Unterweger B; Miller C; Hinterhuber H
Psychopharmacol Bull; 1989; 25(1):97-100. PubMed ID: 2570438
[No Abstract] [Full Text] [Related]
12. Comment on 'reduced haloperidol does not interfere with antipsychotic activity of halperidol in the treatment of acute schizophrenia'.
Altamura AC; Bareggi SR
Int Clin Psychopharmacol; 2000 Sep; 15(5):303-4. PubMed ID: 10993133
[No Abstract] [Full Text] [Related]
13. Comparison of schizophrenia drugs often favors firm funding study.
Vendantam S
Washington Post; 2006 Apr; ():A1, A6. PubMed ID: 16856276
[No Abstract] [Full Text] [Related]
14. Prevention of relapse in schizophrenia.
Geddes J
N Engl J Med; 2002 Jan; 346(1):56-8. PubMed ID: 11778005
[No Abstract] [Full Text] [Related]
15. Implications for future research of "medication-free research in early episode schizophrenia".
Schooler NR
Schizophr Bull; 2006 Apr; 32(2):297-8. PubMed ID: 16481657
[No Abstract] [Full Text] [Related]
16. Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.
Kane JM; Lauriello J; Laska E; Di Marino M; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S29-35. PubMed ID: 18334910
[TBL] [Abstract][Full Text] [Related]
17. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
18. Are new drugs for schizophrenia better than old ones?
Gøtzsche P
Lancet; 2009 Apr; 373(9671):1248; author reply 1249-50. PubMed ID: 19362667
[No Abstract] [Full Text] [Related]
19. Haloperidol decanoate in the treatment of schizophrenia.
Zapletálek M; Zbytovský J
Act Nerv Super (Praha); 1989 Apr; 31(1):39-41. PubMed ID: 2571224
[No Abstract] [Full Text] [Related]
20. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
Woods SW; Gueorguieva RV; Baker CB; Makuch RW
Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
